🇺🇸 LGND — Ligand Pharmaceuticals Incorporated

Salud Compra fuerte
← Volver

Precio actual

306,20 USD

Máx. histórico

322,75

7 días

Split 1603:1000 del 02/11/2022

Caída desde máximo

-5,13%

Rango 52 semanas

175,89 – 326,63

Variación hoy

+2,41%

Cierre anterior

299,00

Rango de hoy

297,84 – 308,26

Volumen hoy

130.173

Peor caída histórica

-93,34%

06/03/2000 → 19/11/2008

Recuperado en 2694 días

Volatilidad anualizada ⓘ

59,76%

Información
Nombre completo
Ligand Pharmaceuticals Incorporated
Divisa
USD
Mercado
NasdaqGM
Sector
Salud
Industria
Biotechnology
Empleados
47
PER ⓘ
122,97 (puede no estar actualizado)
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
351,33 USD (puede no estar actualizado)
Primera cotización
18/11/1992
Precio actualizado
hace 15 horas
Sobre la empresa

Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.

Dividendos repartidos Total últimos 12 meses: 0,0000 USD · Yield: 0,00%
Fecha de pago Importe por participación
03/04/2007 9,3575 USD
Splits Registrados en el histórico de precios
Fecha Ratio
02/11/2022 1603:1000
19/11/2010 1:6
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
22/11/1999 36,49 36,73 34,39 35,09 +1,35% 6,41% 61.261
19/11/1999 36,26 36,49 33,69 34,62 -2,95% 7,74% 51.162
18/11/1999 37,43 37,90 35,56 35,68 -4,69% 6,25% 97.756
17/11/1999 36,73 37,66 36,49 37,43 +1,27% 3,18% 31.659
16/11/1999 37,20 38,25 36,73 36,96 -3,66% 4,09% 71.868
15/11/1999 36,61 38,60 34,62 38,37 +2,82% 10,86% 112.183
12/11/1999 37,90 38,37 36,73 37,31 -0,93% 4,32% 49.292
11/11/1999 37,43 37,90 36,49 37,66 +2,55% 3,75% 60.861
10/11/1999 36,96 38,60 36,26 36,73 -0,32% 6,33% 105.798
09/11/1999 34,62 37,43 34,15 36,85 +9,00% 9,46% 122.362
08/11/1999 33,34 33,80 32,40 33,80 +3,21% 4,21% 77.746
05/11/1999 32,75 33,22 32,05 32,75 +0,72% 3,57% 53.888
04/11/1999 32,52 32,75 31,82 32,52 +2,21% 2,88% 93.749
03/11/1999 30,41 31,82 30,18 31,82 +6,25% 5,38% 37.377
02/11/1999 31,93 32,28 29,94 29,94 -5,19% 7,33% 74.112
01/11/1999 31,11 32,05 31,00 31,58 +3,05% 3,38% 115.282
29/10/1999 29,71 31,46 29,48 30,65 +4,80% 6,69% 119.450
28/10/1999 29,01 29,71 28,54 29,24 +0,81% 4,03% 41.411
27/10/1999 29,36 29,48 28,42 29,01 -1,20% 3,59% 29.121
26/10/1999 29,48 29,94 29,24 29,36 -1,18% 2,38% 25.354
25/10/1999 28,54 29,71 28,54 29,71 +1,60% 4,10% 63.639
22/10/1999 28,54 29,59 28,54 29,24 +2,04% 3,69% 45.686
21/10/1999 28,77 29,01 28,42 28,66 +0,00% 2,03% 31.526
20/10/1999 28,54 29,01 28,42 28,66 +0,41% 2,05% 27.011
19/10/1999 29,24 29,24 28,42 28,54 -0,81% 2,80% 30.083
18/10/1999 28,77 29,48 28,07 28,77 +1,65% 4,88% 47.903
15/10/1999 28,42 28,54 28,07 28,31 -2,02% 1,65% 77.719
14/10/1999 29,48 29,48 28,54 28,89 -1,59% 3,17% 35.186
13/10/1999 28,77 29,94 28,77 29,36 +1,21% 4,07% 56.532
12/10/1999 29,71 29,71 29,01 29,01 -0,80% 2,36% 28.587